Biotech Accord Healthcare receives positive CHMP opinion for IMULDOSA®, a ustekinumab biosimilar to Stelara® October 19, 2024
Biotech 111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 – Conference Call to Follow October 18, 2024
Biotech Evergreen Theragnostics opens CCK2-VIEW, a Phase II small cell lung cancer clinical trial, in the European Union October 18, 2024
Biotech LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing October 18, 2024
Biotech Kexing Biopharm made its appearance at CPHI Milan 2024: Launch Ceremony for Apexelsin® in EU market Successfully done October 17, 2024
Biotech AMSilk Announces Successful Partnership Negotiation with Ajinomoto for Industrial Fermentation October 16, 2024
Biotech Commit Biologics appoints Mikkel Wandahl Pedersen as Chief Scientific Officer October 15, 2024
Search
Biotech
October 19, 2024
October 19, 2024
October 18, 2024
October 18, 2024
October 18, 2024
October 17, 2024
October 17, 2024
October 16, 2024
October 15, 2024
October 15, 2024
